These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinicopathological features and treatment of aggressive natural killer cell leukemia: case series and literature review. Ni Y; Li L; Wang Y; Sun L Turk J Pediatr; 2024 Oct; 66(4):481-489. PubMed ID: 39387420 [TBL] [Abstract][Full Text] [Related]
4. Hemophagocytosis in a patient with persistent chronic lymphocytic leukemia. Kamangar E; Zhao W Blood; 2013 Sep; 122(13):2149. PubMed ID: 24195125 [No Abstract] [Full Text] [Related]
5. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia. Park JA; Jun KR; Nam SH; Ghim TT Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023 [TBL] [Abstract][Full Text] [Related]
6. Long term survival in aggressive NK cell leukemia. Patel AP; Ghatak SB; Patel JA Indian Pediatr; 2010 Sep; 47(9):807-8. PubMed ID: 21048272 [TBL] [Abstract][Full Text] [Related]
7. Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement. Jin X; Xu Y; Zhang J; Li G; Huang D; Yang Y; He H Diagn Pathol; 2017 Jun; 12(1):46. PubMed ID: 28623913 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood. Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980 [TBL] [Abstract][Full Text] [Related]
9. Extensive Hemophagocytic Lymphohistiocytosis Associated With Aggressive Natural Killer Cell Leukemia. Zhang X; Shi M Mayo Clin Proc; 2023 Sep; 98(9):1345-1346. PubMed ID: 37661142 [No Abstract] [Full Text] [Related]
10. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Delavigne K; Bérard E; Bertoli S; Corre J; Duchayne E; Demur C; Mansat-De Mas V; Borel C; Picard M; Alvarez M; Sarry A; Huguet F; Récher C Haematologica; 2014 Mar; 99(3):474-80. PubMed ID: 24142998 [TBL] [Abstract][Full Text] [Related]
12. Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature. Liu Y; Fan L; Zhao H; Xu W; Li J Oncotarget; 2017 May; 8(19):32292-32297. PubMed ID: 28427176 [TBL] [Abstract][Full Text] [Related]
13. Mast cell leukemia and hemophagocytosis in a patient with myelodysplastic syndrome. Yang J; Gabali A Blood; 2019 May; 133(20):2243. PubMed ID: 31097536 [No Abstract] [Full Text] [Related]
14. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia. Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507 [TBL] [Abstract][Full Text] [Related]
15. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature. Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of aggressive natural killer cell leukemia]. Liu EB; Chen HS; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):810-4. PubMed ID: 22336205 [TBL] [Abstract][Full Text] [Related]